Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Supplemental materials for article examining the incidence and impact of chemotherapy induced peripheral neuropathy on clinical and economic outcomes in women with metastatic breast cancer initiating intravenous paclitaxel/nab-paclitaxel.

Articles in this issue

---

ASH 2020: Clinical Updates

ASH 2020: COVID-19 and Hematology

ASH 2020: CAR T-Cell Therapy Updates

ASH 2020: The Next Wave

2020 SABCS: Topics in Precision Oncology

Lauren M. Corduck, Founder of Oneinforty, Dies at 49; Advocated for Change in BRCA Testing Guidelines

Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Supplemental Material: Chemotherapy-Induced Peripheral Neuropathy in Metastatic Breast Cancer Patients Initiating Intravenous Paclitaxel/nab-Paclitaxel

Clinical and Economic Burden of Intravenous Paclitaxel or nab-Paclitaxel for Metastatic Breast Cancer

Supplemental Material: Clinical and Economic Burden of Intravenous Paclitaxel or nab-Paclitaxel for Metastatic Breast Cancer

Related Videos

Related Content

Advertisement

June 12th 2025

How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid

Benjamin Howell, PhD, MPP Leah Ramirez, MS Kristin Austin, MPH Sara Varner, MPH Bryony Winn, MPhil Tiffany Inglis, MD

Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.

October 30th 2023

Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening

Pearl Steinzor

On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.

June 6th 2025

Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder

Sarah J. Marks, MS Valentina Vega, MPH David Zhu, BSc Hannah Shadowen, PhD Ashley Harrell, LCSW Jason Lowe, MSW Andrew Mitchell, PhD Andrew J. Barnes, PhD Peter J. Cunningham, PhD

Accessing medical and social resources for patients, heavy administrative burden, and lack of data integration are barriers to Medicaid managed care organization care coordinators’ job performance.

February 22nd 2022

The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer

On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.

June 5th 2025

Pharmacist-Driven SMART Formulary Improves Pharmacoequity

Erin Van Meter, PharmD, BCACP Caitlin Dowd-Green, PharmD, BCPS, BCACP, MBA Shay Roth, PharmD Robert Green, PharmD, BCGP Amanda Bertram, MS Rosalyn Stewart, MD, MS, MBA

A large academic medical center implemented a charitable care formulary with clinical pharmacist oversight, which resulted in more efficient usage of funds and fewer readmissions.

June 5th 2025

Use of Voluntary Alignment in the Next Generation ACO Model

Tyler Boese, MS Bryan E. Dowd, PhD Roger D. Feldman, PhD Kathleen Rowan, PhD Woolton Lee, PhD Devi Chelluri, MS Susan Cahn, DrPH Shriram Parashuram, PhD

Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.

Related Content

Advertisement

June 12th 2025

How Value-Based Care With Provider Enablement Improves Maternal and Infant Outcomes in Medicaid

Benjamin Howell, PhD, MPP Leah Ramirez, MS Kristin Austin, MPH Sara Varner, MPH Bryony Winn, MPhil Tiffany Inglis, MD

Supported value-based care improves prenatal care while reducing neonatal intensive care unit stays, preterm birth rates, low birth weight rates, and costs for mothers and infants.

October 30th 2023

Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening

Pearl Steinzor

On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.

June 6th 2025

Challenges Faced by Medicaid Managed Care Coordinators Working With Members With Substance Use Disorder

Sarah J. Marks, MS Valentina Vega, MPH David Zhu, BSc Hannah Shadowen, PhD Ashley Harrell, LCSW Jason Lowe, MSW Andrew Mitchell, PhD Andrew J. Barnes, PhD Peter J. Cunningham, PhD

Accessing medical and social resources for patients, heavy administrative burden, and lack of data integration are barriers to Medicaid managed care organization care coordinators’ job performance.

February 22nd 2022

The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer

On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.

June 5th 2025

Pharmacist-Driven SMART Formulary Improves Pharmacoequity

Erin Van Meter, PharmD, BCACP Caitlin Dowd-Green, PharmD, BCPS, BCACP, MBA Shay Roth, PharmD Robert Green, PharmD, BCGP Amanda Bertram, MS Rosalyn Stewart, MD, MS, MBA

A large academic medical center implemented a charitable care formulary with clinical pharmacist oversight, which resulted in more efficient usage of funds and fewer readmissions.

June 5th 2025

Use of Voluntary Alignment in the Next Generation ACO Model

Tyler Boese, MS Bryan E. Dowd, PhD Roger D. Feldman, PhD Kathleen Rowan, PhD Woolton Lee, PhD Devi Chelluri, MS Susan Cahn, DrPH Shriram Parashuram, PhD

Use of voluntary alignment attribution by Next Generation Accountable Care Organization (ACO) participants was limited. The authors highlight the reasons and describe organizational use cases via a mixed-methods approach.